Ouro Medicines
San Francisco
About Ouro Medicines
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven history of progressing cell-depleting treatments through clinical trials, and a strong pipeline.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $120.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: ouromedicines.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/ouro-medicines-66289 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.